4
Changes in Ownership
Maze Therapeutics, Inc. Filed Acc 0000950170-25-013760
10% owner acquired 6,713,588 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Third Rock Ventures IV, L.P. · 10% owner
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-02-03 | Conversion : show line 1 in the form | +5,762,788 | 6,073,958 | D |
| 2025-02-03 | Conversion : show line 2 in the form | +950,800 | 950,800 | I |
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-02-03 | Conversion : show line 3 in the form Series A Preferred Stock | −45,833,334 | 0 | D |
| 2025-02-03 | Conversion : show line 4 in the form Series D-1 Preferred Stock | −9,725,709 | 0 | D |
| 2025-02-03 | Conversion : show line 5 in the form Series A Preferred Stock | −9,166,666 | 0 | I |
Loading xslF345X05/ownership.xml…